Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Metastasis from malignant tumor of prostate
0.010 Biomarker disease BEFREE Overall, our findings indicate that DLL3 is preferentially expressed in CRPC-NE and provide rationale for targeting DLL3 in patients with DLL3-positive metastatic prostate cancer. 30894499 2019